Teachers Retirement System of The State of Kentucky bought a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 33,840 shares of the company’s stock, valued at approximately $1,684,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Allworth Financial LP grew its position in Heartflow by 116.4% in the third quarter. Allworth Financial LP now owns 1,145 shares of the company’s stock worth $57,000 after acquiring an additional 616 shares in the last quarter. Pier 88 Investment Partners LLC bought a new stake in Heartflow during the third quarter worth approximately $174,000. M&G PLC purchased a new stake in Heartflow during the third quarter valued at approximately $15,978,000. Pictet Asset Management Holding SA purchased a new stake in Heartflow during the third quarter valued at approximately $551,000. Finally, Inscription Capital LLC bought a new stake in shares of Heartflow in the 3rd quarter valued at approximately $209,000.
More Heartflow News
These are some of the HTFL news items that stood out recently:
- Negative Sentiment: Filings reported two November 17 sales totaling 36,345 shares at an average of $46.39, alongside another sale of 12,157 shares on October 22 at $55.01. The disclosures also describe additional sales earlier in the year. Repeated insider selling can weigh on sentiment, though the sales were conducted under a pre-arranged plan. SEC Form 4 filing
Heartflow Stock Performance
NASDAQ HTFL opened at $44.63 on Friday. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $60.65. The company’s 50-day moving average price is $51.82 and its 200-day moving average price is $35.55.
Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.15. The firm had revenue of $72.86 million during the quarter. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. During the same quarter in the previous year, the firm posted ($0.27) EPS. As a group, equities research analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current year.
Insider Activity at Heartflow
In other Heartflow news, CEO John Farquhar sold 38,900 shares of the stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $55.74, for a total transaction of $2,168,286.00. Following the transaction, the chief executive officer directly owned 251,983 shares in the company, valued at $14,045,532.42. This represents a 13.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Vikram Verghese sold 3,587 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $53.15, for a total transaction of $190,649.05. Following the completion of the sale, the chief financial officer directly owned 149,587 shares of the company’s stock, valued at $7,950,549.05. The trade was a 2.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 323,936 shares of company stock worth $16,355,191 over the last three months. 7.70% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Several analysts recently weighed in on the company. UBS Group started coverage on Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price target on the stock. Robert W. Baird lifted their price objective on shares of Heartflow from $56.00 to $68.00 and gave the stock an “outperform” rating in a research note on Friday, November 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Heartflow in a research report on Wednesday, November 4th. Benchmark reissued a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Finally, Canaccord Genuity Group raised their target price on shares of Heartflow from $56.00 to $69.00 and gave the stock a “buy” rating in a report on Friday, November 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $60.12.
Get Our Latest Stock Analysis on HTFL
About Heartflow
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Featured Stories
- Five stocks we like better than Heartflow
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
